featured
Efficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and Effectiveness of an rVSV-Vectored Vaccine in Preventing Ebola Virus Disease: Final Results From the Guinea Ring Vaccination, Open-Label, Cluster-Randomised Trial (Ebola Ça Suffit!)
Lancet 2016 Dec 22;[EPub Ahead of Print], AM Henao-Restrepo, A Camacho, IM Longini, CH Watson, WJ Edmunds, M Egger, MW Carroll, NE Dean, I Diatta, M Doumbia, B Draguez, S Duraffour, G Enwere, R Grais, S Gunther, PS Gsell, S Hossmann, SV Watle, MK Kondé, S Kéïta, S Kone, E Kuisma, MM Levine, S Mandal, T Mauget, G Norheim, X Riveros, A Soumah, S Trelle, AS Vicari, JA Røttingen, MP KienyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.